Human T-lymphotropic virus type I (HTLV-I) provirus load was examined in a cohort of a
population in Guinea-Bissau among whom human immunodeficiency virus (HIV) type 2 is …

Human T-lymphotropic virus type II (HTLV-II) has not yet been associated with any disease.
Little is known about the proviral loads of HTLV-II in vivo and its relationship, if any, to lack of …

Several reports suggest that HTLV-I/HIV coinfection may be associated with an increased
risk of HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP). In HTLV-I …

Human T lymphotropic virus type I (HTLV-I) can increase human immunodeficiency virus
(HIV) replication in vitro, and several studies suggest that HTLV-I accelerates the …

Human T-lymphotropic virus type II (HTLV-II) is a human retrovirus which is endemic in
Amerindian and pygmy tribes. Molecular subtypes show geographic segregation consistent …

Human T-lymphotropic virus type I (HTLV-I) and HTLV-II have been postulated to accelerate
disease progression in patients coinfected with HIV. However, recent evidence suggests that …

To determine whether human T-lymphotropic virus (HTLV) type II coinfection affects
progression of human immunodeficiency virus type 1 (HIV) infection, longitudinal data on …

Reports indicate that there is a dissociation between markers of HIV disease progression
and clinical stage among subjects coinfected with human T-cell lymphotropic virus type I …

Background. Human T lymphotropic virus types 1 (HTLV-1) and 2 (HTLV-2) are frequent
copathogens among individuals infected with human immunodeficiency virus type 1 (HIV-1) …

Human T‐cell lymphotropic virus (HTLV) types I and II were the first discovered human
retroviruses. While HTLV‐I has been clearly associated with disease, the health implications …